A strong signature associated with estrogen receptor 1 (ESR1) was observed (Fig 5D), with estrogen having anti-inflammatory properties and believed to be associated with reduced COVID-19 severity in women [77–79], and reduced SARS-CoV disease severity in female mice [59, 80]. This evidence concerns the gene ESR1 and COVID-19.